We are live on ! Find out more
NERM

New England Research & Management Portfolio holdings

AUM $257M
1-Year Est. Return 25.66%
This Fund
S&P 500
This Quarter Est. Return
+10.71%
1 Year Est. Return
+25.66%
3 Year Est. Return
+56.38%
5 Year Est. Return
+58.71%
10 Year Est. Return
+176.32%
AUM
$162M
AUM Growth
+$23.6M
Cap. Flow
+$10.6M
Cap. Flow %
6.58%
Top 10 Hldgs %
23.45%
Holding
171
New
38
Increased
27
Reduced
58
Closed
21

Top Buys

Rank Stock Value
1
APD icon
Air Products & Chemicals
APD
+$1.92M
2
LOW icon
Lowe's Companies
LOW
+$1.92M
3
MMM icon
3M
MMM
+$1.39M
4
CARR icon
Carrier Global
CARR
+$1.29M
5
KMX icon
CarMax
KMX
+$1.02M

Top Sells

Rank Stock Value
1
LDOS icon
Leidos
LDOS
+$1.17M
2
NVS icon
Novartis
NVS
+$1.09M
3
CHGG icon
Chegg
CHGG
+$1.07M
4
TER icon
Teradyne
TER
+$976K
5
LLY icon
Eli Lilly
LLY
+$929K

Sector Composition

Rank Sector Weight
1 Industrials 18.77%
2 Healthcare 18.64%
3 Technology 17.5%
4 Consumer Staples 14.2%
5 Consumer Discretionary 9.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LITE icon
126
Lumentum
LITE
$75.3B
$327K 0.2%
3,450
OC icon
127
Owens Corning
OC
$10.2B
$316K 0.2%
4,175
-7,150
-63% -$521K
SHW icon
128
Sherwin-Williams
SHW
$78.5B
$312K 0.19%
1,275
CRUS icon
129
Cirrus Logic
CRUS
$6.12B
$306K 0.19%
3,725
TRN icon
130
Trinity Industries
TRN
$2.24B
$306K 0.19%
11,583
-13,200
-53% -$297K
BA icon
131
Boeing
BA
$166B
$305K 0.19%
+1,425
New +$274K
EVRG icon
132
Evergy
EVRG
$18.5B
$300K 0.19%
5,400
-11,350
-68% -$623K
IDXX icon
133
Idexx Laboratories
IDXX
$40.2B
$300K 0.19%
600
NEE icon
134
NextEra Energy
NEE
$169B
$291K 0.18%
+3,775
New +$282K
JPM icon
135
JPMorgan Chase
JPM
$937B
$276K 0.17%
2,173
-450
-17% -$50.3K
STZ icon
136
Constellation Brands
STZ
$21.1B
$274K 0.17%
1,250
GE icon
137
GE Aerospace
GE
$319B
$273K 0.17%
5,064
-241
-5% -$10.8K
J icon
138
Jacobs Solutions
J
$17B
$272K 0.17%
3,022
-9,945
-77% -$843K
XYL icon
139
Xylem
XYL
$25.1B
$265K 0.16%
2,600
BBY icon
140
Best Buy
BBY
$19.6B
$254K 0.16%
+2,550
New +$285K
SWKS icon
141
Skyworks Solutions
SWKS
$13.5B
$248K 0.15%
1,625
BSX icon
142
Boston Scientific
BSX
$63.6B
$247K 0.15%
6,875
-25,663
-79% -$925K
PNR icon
143
Pentair
PNR
$9.03B
$223K 0.14%
+4,191
New +$215K
ALL icon
144
Allstate
ALL
$65B
$220K 0.14%
+2,000
New +$197K
EA
145
DELISTED
Electronic Arts
EA
$215K 0.13%
1,500
-3,985
-73% -$514K
INTU icon
146
Intuit
INTU
$88B
$209K 0.13%
+550
New +$193K
DRI icon
147
Darden Restaurants
DRI
$23.7B
$208K 0.13%
+1,750
New +$187K
AKAM icon
148
Akamai
AKAM
$15.1B
-2,850
Closed -$315K
AMGN icon
149
Amgen
AMGN
$203B
-1,400
Closed -$356K
BALL icon
150
Ball Corp
BALL
$16.1B
-3,550
Closed -$295K

Similar funds

New England Research & Management's Q4 2020 Portfolio in Review

As of Q4 2020, New England Research & Management held 171 positions worth $162M, up 17% from $138M the previous quarter. Its ten largest holdings account for 23% of the portfolio.

New England Research & Management deployed $10.6M of net new capital in Q4 2020, opening 38 new positions and adding to 27 existing holdings. Its largest new stake was Air Products & Chemicals: 6,825 shares worth $1.86M.

By sector, the portfolio is most concentrated in Industrials at 19% of assets, up from 15% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Teradyne, an estimated $976K trimmed.

  • New England Research & Management's largest Q4 2020 buy was Air Products & Chemicals: 6,825 shares worth $1.86M.
  • New England Research & Management added most to 3M in Q4 2020, an estimated $1.39M increase.
  • New England Research & Management's biggest Q4 2020 reduction was Teradyne, cutting an estimated $976K.
  • New England Research & Management fully exited Leidos in Q4 2020, selling an estimated $1.17M.
  • New England Research & Management's ten largest holdings make up 23% of its $162M portfolio in Q4 2020.
  • New England Research & Management opened 38 new positions and closed 21 in Q4 2020.
  • New England Research & Management's portfolio value rose 17% quarter-over-quarter to $162M.

Based on New England Research & Management's 13F filing for Q4 2020, filed 7 Jan 2021.